Dietmar Berger (Sanofi)
Ending a grueling 10-year drought, Sanofi finally wins an OK for an in-house cancer drug
Sanofi has snagged an FDA approval for a top drug in its pipeline, ending a 10-year drought of home-grown cancer drug approvals as the new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.